Trial intelligence / Profile preview

Onset of Action of Mometasone Furoate in Allergic Rhinitis

NCT00783237Phase 4Completed

Sponsor
Organon & Co.
Start
Dec 2003
Primary completion
Feb 2004
Modality
Small Molecules
01

Overview

A Phase 4 trial of mometasone furoate nasal spray in allergic rhinitis (AR), sponsored by Organon & Co.. Started Dec 2003; status: completed.

02

Drugs

mometasone furoate nasal spray
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NCT00783237.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00783237.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call